Current Status
Not Enrolled
Price
Free
Get Started

Understanding the Global Differences in Lysosomal Disorders for Patient Care

GRIDS-2024 10th Anniversary CME Program

To obtain CME/CE credit, you must LOG-IN and ENROLL (click the button at top of page)

Start date: Jan 1, 2025
End date: Dec 31, 2025

Estimated time to complete: 2.0 hours

Credits: 2.0 AMA PRA Category 1 Credits™

Other Modules in this Series

Free

Optimizing the Efficacy and Safety of Therapy for Fabry Disease

Free

Overview of Epigenetics and Epigenomics in Lysosomal Disorders

Free

Epigenetic and Epigenomics Signature in Lysosomal Disorders Pathology

Free

Epigenetic Modifiers as Therapeutic Targets

Lysosomal & Rare Disorders Research & Treatment Center

GRIDS-2024 10th Anniversary CME Program

Understanding the Global Differences in Lysosomal Disorders for Patient Care

This activity was supported by educational grants from Lilly, Sanofi, Amicus and Takeda

Continuing Education Information

This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available to other attendees.

Learning Objectives

At the end of this activity, participants should be able to address one or more of the following:

  • Discuss the global overview of lysosomal disorders, epigenomics and geographic variations
  • State the global changes in MPS epidemiology and related biology as revealed by transcriptomic studies
  • Review the Phenotypic spectrum of Gaucher disease in populations from South America
Krista Casazza, PhD, RD, CSSD
Scientific Director, Pediatrics, CPLD, Arizona, USA.

Uma Ramaswami, FRCPCH, MD
Consultant in Inherited Metabolic Disorders, Honorary Associate Professor Genetics and Genomic Medicine, UCL. Clinical Lead, Lysosomal Storage Disorders Unit Institute of Infection, Immunity and Rare Diseases Royal Free London NHS Foundation Trust, UK.

Ida Vanessa D. Schwartz, MD, PhD
Professor, Genetics Department, Biosciences Institute, Universidade Federal do Rio Grande do Sul, Porto Allegre, Brazil.

Leyla Namazova-Baranova, MD, PhD
Head of Pediatric Department, Research Institute of Pediatrics and Children’s Health Protection, Pirogov Russian National Research Medical University, Moscow, Russia.

Orna Staretz-Chacham, MD
Senior Neonatologist Metabolic Clinic, Rare Disease Center, Director of Soroka Medical Centre, Israel.

Faculty Disclosures

Dr. Krista Casazza has no relevant financial interest with an ineligible company to disclose.
Dr. Uma Ramaswami Is a member of the Speakers Bureau for: Amicus, Chiesi, Takeda.
She is also a member of the Advisory Board for: Amicus, Chiesi, Sanofi.
Dr. Ida Vanessa Doederlein Schwartz receives grant funding from Ultragenyz Inc, PTC Inc, and Spur Therapeutics. She ia also on the advisory board for Takeda.
Dr. Leyla S. Namazova-Baranova has no relevant financial interest with an ineligible company to disclose.
Dr. Oma Staretz Chacham has no relevant financial interest with an ineligible company to disclose.

Disclosures

AffinityCE staff, LDRTC staff, CheckRare CE staff, planners, and reviewers, have no relevant financial interests to disclose. All faculty disclosures are listed below and will be stated prior to the start of each session.

Mitigation of Relevant Financial Relationships

AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships reported have been mitigated prior to the commencement of the activity through peer review of content by non-conflicted reviewers.

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Continuing Nursing Education is provided for this program through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This activity provides a maximum of 2.0 hours of continuing nursing education credit.

Nurse Practitioners

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.

Genetic Counselors
Category 2 CEU

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Genetic Counselors should claim only the credit commensurate with the extent of their participation in the activity.

Other Professionals

All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.

Participation Costs

There is no cost to participate in this activity.

CME Inquiries

For all CME policy-related inquiries, please contact us at ce@affinityced.com.
Send customer support requests to cds_support+ldrtc@affinityced.com.